Pep2Tango Therapeutics

Pep2Tango Therapeutics is a developer of peptide drugs aimed at addressing unmet medical needs. The company offers single-molecule multi-receptor peptide agonists targeting GLP-1, GIP, amylin, and calcitonin receptors, which have advantages over first-generation drugs, enabling pharmaceutical companies to provide weight-loss therapies.